Carl Beyer, MD - Penn Medicine
Predictors of Initial Management Failure in Traumatic Hemothorax: A Prospective Multicenter Analysis

Johanna Lou, MD – Cooper University Hospital
The Early Impact of COVID-19 on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center

Rami Mustafa, MD – Abington Jefferson Health
Can we answer the question “How old is too old for bariatric surgery?

Alexander Fagenson, MD– Temple University Hospital
Intrahepatic Cholangiocarcinoma: How Do Hepatectomy Outcomes Compare to Liver Metastases and Hepatocellular Carcinoma?

Claire B. Rosen, MD – Penn Medicine
Multimorbidity Confers Greater Risk for Older Patients in Emergency General Surgery than the Presence of Multiple Comorbidities

Ryan Lamm, MD- Thomas Jefferson University Hospital
The Impact of the pandemic on melanoma presentation-a COVID-19 cancer canary coal mine

Sara Ginzberg, MD – Penn Medicine
Disparities in Appropriate Thyroid Cancer Treatment, Before and After the Release of the 2015 American Thyroid Association Guidelines

Theodore E. Habarth-Morales, NRAEMT, MS3- Sidney Kimmel Medical College-Jefferson
Direct To OR Resuscitation of Abdominal Trauma: An NTDB Propensity Matched Outcomes Study

Keshav Kooragayala, MD- Cooper University Hospital
Impact of Adipose-derived Stem Cells on Aortic Tensile Strength in an AAA model

Jacqueline Soegaard, MD – Penn Medicine
Preoperative History and Physical Update Visits May Be Suitable for Telehealth

Kaitlyn Kennard, MD – Lankenau Medical Main Line
Management of Hormone Receptor Positive Breast Cancer in Women 80 Years and Older: Is Surgery Best

Caitlin Finn, MD – Penn Medicine
Data-Informed Hospital Selection to Achieve Health Equity: An Economic Simulation

Arturo J. Rios-Diaz, MD – Thomas Jefferson University
Longitudinal Morbidity and Healthcare Utilization Following Elective and Emergent Paraesophageal Hernia Repair: A Nationwide Analysis of Readmissions, Recurrence and Reinterventions

Jason K. C. Tong, MD – Penn Medicine
Evaluating Changes in Surgical Outcomes for Patients with Inflammatory Bowel Disease Following Medicaid Expansion

Georgianna Sandilos, MD – Cooper University Hospital
CDK-9 Inhibition Augments the Efficacy of Epigenetic Therapies in Pancreatic Ductal Adenocarcinoma